• Mumtaz Ali Shaikh
  • Saima Gillani
  • Dur -E- Yakta


Background: Diabetic retinopathy is one of the most common and serious complications of type 2diabetes mellitus and a leading cause of blindness not only in Pakistan but also worldwide. So weconducted this study to record the frequency of diabetic retinopathy in known diabetic patients ten yearsafter diagnosis of type 2 diabetes mellitus. Methods: The study was conducted at Liaquat University ofMedical and Health Sciences, Jamshoro, Pakistan for a period of 1 year from January 2008 to January2010. The study group comprised of 200 patients of type 2 diabetes mellitus attending the medicalclinic. All patients who were diagnosed as type 2 diabetes mellitus since ten years duration wereincluded in the study. Retinopathy was graded into background, pre proliferative and proliferativeretinopathy. Type 2 diabetes was diagnosed using the WHO criteria. Statistical analysis was carried outusing the SPSS-11. Results: Diabetic retinopathy was found in 25.5% of the total Type 2 patients afterten years of diagnosis, and of these 4% of patients had proliferative retinopathy. Conclusion: Type 2diabetic patients should be screened as early as possible to prevent permanent visual loss by timelymanagement of diabetic retinopathy because diabetes is one of most common preventable cause ofblindness in the world.Keywords: Retinopathy, Type 2 Diabetes


Tahir I, Jamal Z. Frequency of retinopathy in newly

diagnosed type 2 diabetes mellitus. Rawal Med J


Kalvoda B. Screening for diabetic retinopathy in Czech.

Republic- guidelines. Cesk Slov Oftalmol 2002;58:3–10.

Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B,

McCarty DJ, et al. Aus Diab Study Group. The prevalence of

and factors associated with diabetic retinopathy in Australian

population. Diabetes Care 2003;26:1731–7.

Wahid S, Mehmood N, Shaikh Z, Kazmi H. Frequency of

retinopathy in newly diagnosed type 2 diabetes patient. J Pak

Med Assoc 2008;58:557–61.

Lalit D, Rakhi D, Thomas J, Catherine A, Gullapali N.

Population based assessment of diabetic retinopathy in an

urban population in southern India. Br J Ophthalmol


Tayyab A, Nadeem Q, Khalid S. Screening for Diabetic

Retinopathy: a comparative study between hospital and

community based screening and between paying and non-paying

patients. J Ayub Med Coll Abottabad 2007;19(1):16–22.

Beulens JW, Patel A, Vingerling JR, Cruickshank JK,

Hughes AD, Stanton A, et al. Effects of blood pressure

lowering and intensive glucose control on the incidence and

progression of retinopathy in patients with type 2 diabetes

mellitus: a randomised controlled trial. Diabetologia


Azizul H, Zaffar U, Mohammad Z, Sultan Z, Sobia S.

Awareness diabetic retinopathy amongst known diabetic. J

Postgrad Med Inst 2007;21(1):10–5.

World Health Organization. The WHO diagnostic criteria of

Diabetes of 1999 as revised in 2006 at the 19th World

Diabetes Conference [Internet]. [updated 2009]. Available at:


Daniel E, Jerry D, George. Diabetic Retinopathy. Diabetes

Care 2002;25(Suppl-1):90–3.

Gonzalez EL, Johansson S, Wallander MA, Rodríguez LA.

Trends in the prevalence and incidence of diabetes in the UK:

-2005. J Epidemiol Community Health 2009;63:332–6.

Chew EY, Ambrosius WT, Davis MD, Danis RP,

Gangaputra S, Greven CM, et al. Effects of medical therapies

on retinopathy progression in type 2 diabetes. N Engl J Med


Mahar P, Zahid M, Nabeel M, Saleh. Prevalence of Type-II

Diabetes Mellitus and Diabetic Retinopathy: The Gaddap

Study J Coll Physicians Surg Pak 2010;20:528–32.

Ronald K, Barbara E, Scot E, Matthew D, David L.

Glycosylated Hemoglobin Predicts the Incidence and

Progression of Diabetic Retinopathy. JAMA


Abramoff MD, Reinhardt JM, Russell SR, Folk JC, Mahajan

VB, Niemeijer M, et al. Automated early detection of

diabetic retinopathy. Ophthalmology 2010;117:1147–54.

Scotland GS, McNamee P, Philip S, Fleming AD, Goatman

KA, Prescott GJ, et al. Cost-effectiveness of implementing

automated grading within the national screening programme

for diabetic retinopathy in Scotland. Br J Ophthalmol


West SD, Groves DC, Lipinski HJ, Nicoll DJ, Mason RH,

Scanlon PH, et al. The prevalence of retinopathy in men with

Type 2 diabetes and obstructive sleep apnoea. Diabet Med


Rohit V, Farzana C, Ronald K, Jassica C, Mina T, Stanel P.

Four-Year Incidence and Progression of Diabetic retinopathy

and Macular Edema: The Los Angeles Latino Eye Study.

Am J Ophthalmol 2010;149:752–61.

Klein R, Klein BE, Moss SE, Cruickshanks KJ.. The

Wisconsin Epidemiologic Study of Diabtic Retinopathy. TenYear Incidence and Progression of Diabetic Retinopathy.

Arch Ophthalmol 1994;112:1217–28.

Ronald K, Barbara E, Scot E, Matthew D, David L. The

Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Arch Ophthalmol 1984;102:520–6.

Nancy M, Fang B, Arghavan A, David C. Ischemic Diabetic

Retinopathy May Protect against Nuclear Sclerotic Cataract.

Am J Ophthalmol 2010;150:543–50.

Jermy D. Amy Z, Ronald K. Retinopathy in Nondiabetic

Persons with the Metabolic Syndrome: Findings from the

Third National Health and Nutrition Examination Survey.

Am J Ophthalmol 2009;147:934–44.

Can Supplements Help People With Diabetes Avoid

Retinopathy? Available at:


Management of type 2 diabetes. Retinopathy - screening and

early management, 2002.


Type 2 diabetes: the management of type 2 diabetes, 2009.

Available at:





Most read articles by the same author(s)

1 2 > >>